3,114 results match your criteria Retinitis CMV


HIV and AIDS-defining opportunistic illnesses in the state of Qatar: A cohort population-based retrospective study covering 17 years (2000-2016).

Ann Med Surg (Lond) 2022 Jun 20;78:103842. Epub 2022 May 20.

Department of Infectious Diseases, Hamad Medical Corporation, P.O 3050, Doha, Qatar.

Background And Introduction: Human immune deficiency virus (HIV) infection remains a major health problem since discovery of the virus in 1981. Globally, since introduction of antiretroviral therapy, AIDS-related mortality was reduced by 47% since 2010. Also, HIV-related opportunistic infections (OIs) became less common, especially with use of prophylaxis to prevent such infections. Read More

View Article and Full-Text PDF

The Potential Association of Delayed T Lymphocyte Reconstitution Within Six Months Post-Transplantation With the Risk of Cytomegalovirus Retinitis in Severe Aplastic Anemia Recipients.

Front Cell Infect Microbiol 2022 25;12:900154. Epub 2022 May 25.

Department of Ophthalmology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.

Background: Delayed immune reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT) is significantly associated with cytomegalovirus (CMV) infection. The aim of this study was to observe the recovery trend of peripheral lymphocyte subsets and immunoglobulins in HSCT recipients who developed CMV retinitis (CMVR).

Methods: We identified 37 CMVR cases and 303 non-CMVR controls in this case-control study from a database of 404 consecutive severe aplastic anemia patients who received allogeneic HSCT at a single center between 2015 and 2020. Read More

View Article and Full-Text PDF

Correlation of quantitative polymerase chain reaction with clinical characteristics of patients with viral retinitis.

Indian J Ophthalmol 2022 Jun;70(6):2090-2093

Department of Uvea, SankaraNethralaya, Medical Research Foundation, Chennai, Tamil Nadu, India.

Purpose: To evaluate the correlation of quantitative real-time polymerase chain reaction (qRT-PCR) to the clinical characteristics of patients with viral retinitis.

Methods: Retrospective case series.

Results: Aqueous or vitreous samples of 20 out of 35 eyes showed qRT-PCR positivity for virus etiology (57. Read More

View Article and Full-Text PDF

Study to evaluate efficacy of midriatic-digital-images when screening retinal-complications in people living with HIV.

Int J STD AIDS 2022 May 24:9564624221100941. Epub 2022 May 24.

125822National University of Trujillo, Trujillo, Perú.

To determine efficacy of mydriatic-digital images (MDI) when screening retinal complications in people living with HIV, in this study, a consecutive series of 79 people living with HIV (PLHIV) were evaluated. Two series of MDI were taken: - macula and optic nerve - nine gaze fields, which findings were compared with those obtained by a retina specialist. Both examiners were unaware of each other's results. Read More

View Article and Full-Text PDF

Belatacept and CMV: Severe retinitis and vascular complications, case report.

J Fr Ophtalmol 2022 May 18. Epub 2022 May 18.

Département d'ophtalmologie, hôpital Pitié-Salpêtrière, Université Pierre-et-Marie-Curie Paris VI, boulevard de l'Hôpital, 75013 Paris, France.

View Article and Full-Text PDF

Cytomegalovirus-Immune Recovery Retinitis After Initiation of Highly Active Antiretroviral Therapy: A Case Series.

Front Med (Lausanne) 2022 27;9:807013. Epub 2022 Apr 27.

Department of Ophthalmology, Huashan Hospital of Fudan University, Shanghai, China.

Purpose: To delineate the characteristics and treatment of cytomegalovirus-immune recovery retinitis (CMV-IRR) in human immunodeficiency virus (HIV) patients with immune recovery under effective highly active antiretroviral therapy (HAART) regimen.

Methods: We reported four patients with HIV who were diagnosed with CMV-IRR soon after effective HAART. Plasma levels of CD4 T cells, HAART regimen, and other clinical and laboratory characteristics of the four patients were described. Read More

View Article and Full-Text PDF

Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections.

Hematology 2022 Dec;27(1):535-542

Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong.

Objectives: Bendamustine is a standard treatment for low-grade B-cell lymphomas, and considered safe in clinical trials. Its safety in routine practice might be different.

Methods: We retrospectively analyzed the infection complications in an unselected cohort of patients treated with bendamustine over a nine-year period. Read More

View Article and Full-Text PDF
December 2022

A comparative analysis depicting the disease characteristics and phylogenetic signature of human cytomegalovirus infection in Human Immunodeficiency Virus 1 seropositive patients with end-organ retinitis and gastro-enteric diseases.

Sci Rep 2022 05 10;12(1):7617. Epub 2022 May 10.

ICMR-NICED Virus Laboratory, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, GB4, ID & BG Hospital Campus, Dr. S.C Banerjee road, Beliaghata, Kolkata, West Bengal, 700010, India.

During advanced HIV infection, Human Cytomegalovirus (HCMV) has been proven to produce devitalizing end-organ diseases (EOD). The interactive co-existence of HIV and HCMV has been reported by many researchers and has been suggested to be linked with a more aggressive disease state. This study has been designed to bring forward an assessment of the clinical risk factors capable of defining the conditions of HCMV induced retinitis and gastro-enteric diseases among HIV1 seropositive patients. Read More

View Article and Full-Text PDF

Sociodemographic predictors associated with the spectrum of non-opportunist neuroretinal disease of non-infectious etiology in patients with HIV/AIDS: A scoping review.

Arch Soc Esp Oftalmol (Engl Ed) 2022 May 8;97(5):251-263. Epub 2021 Dec 8.

Fundación Oftalmológica de Santander - FOSCAL, Santander, Colombia; Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.

Background: Non-infectious retinal disease, even in the HAART era, continues to be one of the most common diagnoses in patients with HIV, with prevalences of up to 27% of cases. This study aims to characterize the association between demographic variables and their role. As a risk factor for the development of non-opportunistic non-infectious retinal disease in patients with HIV/AIDS. Read More

View Article and Full-Text PDF

"Vitreous Hemorrhage and Long-Lasting Priapism After COVID-19 m-RNA Based Vaccine: A Case Report".

Eur J Ophthalmol 2022 May 3:11206721221098880. Epub 2022 May 3.

Ophthalmology Unit, 9370University Hospital of Parma, Parma, Italy.

Purpose: To report a case of possible multi-district thromboembolic event involving the eye of a patient with several cardiovascular risk factors, following a second inoculation of SARS-CoV-2 m-RNA based vaccine.

Case-report: A 60-year-old man presented with blurred vision in the left eye lasting 1 month but started within 24 hours from the 2 dose of BNT162b2 vaccine inoculation. He also reported a long-lasting but self-limiting priapism which started about 4 h after the vaccination. Read More

View Article and Full-Text PDF

Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.

Ann Eye Sci 2022 Mar;7

Francis I. Proctor Foundation, University of California, San Francisco, CA, USA.

Cytomegalovirus (CMV) retinitis is an opportunistic infection that has traditionally affected those who have HIV/AIDS or immunosuppressed individuals. CMV retinitis previously infected one-third of AIDS patients in the pre-highly active antiretroviral therapy (HAART) era, but since HAART, Western countries have seen an 80% decrease in the incidence of the disease. More recently, CMV retinitis has been reported in patients who are immunosuppressed, often due to chemotherapy or immunomodulatory medications. Read More

View Article and Full-Text PDF

Temporal trends in ocular manifestations of HIV/AIDS patients in the past 18 years in a tertiary hospital in China.

Graefes Arch Clin Exp Ophthalmol 2022 Apr 23. Epub 2022 Apr 23.

Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.

Purpose: To investigate the ocular manifestation changes in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) patents in a tertiary eye clinic in China over the past 18 years.

Methods: In this retrospective cross-sectional study, 264 HIV/AIDS patients (528 eyes) were recruited at the Department of Ophthalmology, Peking Union Medical College Hospital, from 2001 to 2018. Patients underwent ophthalmic examinations, including best-corrected visual acuity (BCVA), slit-lamp microscopy, and indirect ophthalmoscopy, and completed a registration form including demographic characteristics, medical history, and immune status data. Read More

View Article and Full-Text PDF

Tumors and Cytomegalovirus: An Intimate Interplay.

Authors:
Georges Herbein

Viruses 2022 04 14;14(4). Epub 2022 Apr 14.

Department Pathogens & Inflammation-EPILAB EA4266, University of Franche-Comté UBFC, 25000 Besançon, France.

Human cytomegalovirus (HCMV) is a herpesvirus that alternates lytic and latent infection, infecting between 40 and 95% of the population worldwide, usually without symptoms. During its lytic cycle, HCMV can result in fever, asthenia, and, in some cases, can lead to severe symptoms such as hepatitis, pneumonitis, meningitis, retinitis, and severe cytomegalovirus disease, especially in immunocompromised individuals. Usually, the host immune response keeps the virus in a latent stage, although HCMV can reactivate in an inflammatory context, which could result in sequential lytic/latent viral cycles during the lifetime and thereby participate in the HCMV genomic diversity in humans and the high level of HCMV intrahost genomic variability. Read More

View Article and Full-Text PDF

Cytomegalovirus Retinitis Screening Using Machine Learning Technology.

Retina 2022 Apr 11. Epub 2022 Apr 11.

Department of ophthalmology, Faculty of medicine, Khon Kaen University.

Propose: A screening protocol for cytomegalovirus retinitis (CMVR) by fundus photography was generated and the diagnostic accuracy of machine learning technology for CMVR screening in HIV patients was investigated.

Methods: One hundred and sixty-five eyes of ninety HIV positive patients were enrolled and evaluated for CMVR with binocular indirect ophthalmoscopy. Then, a single central field of the fundus image was recorded from each eye. Read More

View Article and Full-Text PDF

Rapidly Progressive Neovascular Glaucoma Associated with Atypical Cytomegalovirus Retinitis: A Case Report.

Korean J Ophthalmol 2022 04 4;36(2):171-179. Epub 2022 Apr 4.

Department of Ophthalmology, Hanyang University Guri Hospital, Guri, Korea.

View Article and Full-Text PDF

Post-CD19 Chimeric Antigen Receptor T-Cell Therapy Cytomegalovirus Retinitis.

Cureus 2022 Mar 9;14(3):e23002. Epub 2022 Mar 9.

Ophthalmology, King Abdulaziz Medical City, Riyadh, SAU.

The purpose of this case report was to present a case of cytomegalovirus (CMV) retinitis in a patient with diffuse large B-cell lymphoma (DLBCL) post-CD19 chimeric antigen receptor (CAR) T-cell therapy. A 43-year-old female patient who was complaining of metamorphopsia and sudden blurring in the vision of her left eye was referred to the ophthalmology department. The patient had DLBCL and was started on systemic chemotherapy, which showed no response to therapy and disease progression. Read More

View Article and Full-Text PDF

Cytomegalovirus retinitis and antiretroviral treatment: A fifteen year experience.

South Afr J HIV Med 2022 8;23(1):1322. Epub 2022 Mar 8.

Biostatistics Unit, Faculty of Health Sciences Management, Nelson Mandela University, Gqeberha, South Africa.

Background: South Africa's public antiretroviral treatment (ART) programme has undergone progressive changes since its introduction in 2004. The effect of this on the burden of the AIDS-defining opportunistic infection, cytomegalovirus retinitis (CMVR), in SA, has not been fully appreciated.

Objectives: To determine the effect of ART availability in the public sector of SA on the trend in the number of cases of newly diagnosed CMVR over time. Read More

View Article and Full-Text PDF

Human immune deficiency virus conundrum: An everlasting challenge!

Oman J Ophthalmol 2022 Jan-Apr;15(1):13-19. Epub 2022 Mar 2.

Department of Ophthalmology, SP Medical College, Bikaner, Rajasthan, India.

Background: Human immune deficiency virus (HIV) causes a wide spectrum of diseases worldwide and has the capability to affect every organ system in the body. Ocular manifestations have been reported in up to 70% of individuals infected with HIV and the ocular manifestations reflect systemic disease and maybe the first sign of disseminated infection.

Purpose: To study the pattern of ocular manifestations related to HIV in seropositive patients with the objective of identifying its spectrum in highly active antiretroviral therapy (HAART) era and to emphasize on the role of ophthalmologists in fighting the battle against HIV. Read More

View Article and Full-Text PDF

Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation: Can we develop a screening protocol?

Oman J Ophthalmol 2022 Jan-Apr;15(1):1-2. Epub 2022 Mar 2.

Ophthalmology Residency Program, Oman Medical Speciality Board, Muscat, Oman.

View Article and Full-Text PDF

Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia.

Front Cell Infect Microbiol 2022 15;12:870296. Epub 2022 Mar 15.

Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.

Background: Cytomegalovirus retinitis is a severe, vision-threatening opportunistic infection in an immunodeficient population. Reports on cytomegalovirus retinitis in hematopoietic stem cell transplant recipients due to severe aplastic anemia have been scant. This study assessed the risk of cytomegalovirus retinitis in relation to the pre-transplant status of severe aplastic anemia patients. Read More

View Article and Full-Text PDF

Simultaneous Occurrence of Cytomegalovirus Colitis and Retinitis as the Initial Presentation of Human Immunodeficiency Virus Infection in a Patient With Zero CD4 Count.

Cureus 2022 Feb 21;14(2):e22455. Epub 2022 Feb 21.

Medicine/Infectious Diseases, King Abdulaziz Medical City, Jeddah, SAU.

Cytomegalovirus (CMV) can be a reason for severe disease in immunocompromised patients, either via the reactivation of latent CMV infection or via the acquisition of primary CMV infection. Clinical syndromes that may be observed are retinitis, colitis, esophagitis, encephalitis, pneumonitis, hepatitis, uveitis, and graft rejection following transplantation. The simultaneous occurrence of CMV colitis and retinitis as the initial presentation of human immunodeficiency virus (HIV) infection is extremely rare. Read More

View Article and Full-Text PDF
February 2022

An Unusual Cytomegalovirus Ocular Manifestation in a Non-HIV Patient.

Cureus 2022 Feb 5;14(2):e21947. Epub 2022 Feb 5.

Ophthalmology, Hospital Kuala Lumpur, Kuala Lumpur, MYS.

A 60-year-old Aboriginal man with underlying severe exfoliative dermatitis, treated with oral azathioprine and oral prednisolone, presented with left painful red eye for ten days. On initial presentation, left eye vision was poor at hand motion. There was corneal endotheliitis over the left eye with severe anterior chamber inflammation obscuring the fundus view. Read More

View Article and Full-Text PDF
February 2022

Development and pharmacokinetic evaluation of osmotically controlled drug delivery system of Valganciclovir HCl for potential application in the treatment of CMV retinitis.

Drug Deliv Transl Res 2022 Mar 7. Epub 2022 Mar 7.

Shree Goraksha College of Pharmacy & Research Centre, Khamgaon, 431151, Maharashtra, India.

Valganciclovir HCl (VGH) is the widely used drug for the treatment of cytomegalovirus (CMV) retinitis infection with an induction dose of 900 mg per oral (p.o.) twice a day and a maintenance dose of 900 mg (p. Read More

View Article and Full-Text PDF

Bilateral cytomegalovirus retinitis as the presenting feature of Dyskeratosis Congenita.

Eur J Ophthalmol 2022 Mar 4:11206721221086154. Epub 2022 Mar 4.

Advanced Eye Centre, 29751Post Graduate Institute of Medical Education and Research, Chandigarh-160012, India.

Purpose: To describe a young male with bilateral sequential Cytomegalovirus retinitis (CMVR) as the presenting feature of Dyskeratosis Congenita.

Case Report: A 25-year-old human immunodeficiency virus (HIV) negative male developed CMVR in his left eye, while on a three week course of oral valganciclovir therapy for CMV retinitis in his right eye. Systemic examination revealed reticular hypopigmentation of the forearms, dystrophic nails, oral leukoplakia and complete blood counts showed pancytopenia. Read More

View Article and Full-Text PDF

Rare cause of left eye floaters and blurred vision in an immunocompromised patient: acute retinal necrosis (ARN).

BMJ Case Rep 2022 Mar 2;15(3). Epub 2022 Mar 2.

Department of Ophthalmology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China

Acute retinal necrosis (ARN) is a clinical syndrome featuring severe vitritis and occlusive vasculitis characterised by full thickness necrotising retinitis. ARN is usually caused by an acute infection by either varicella zoster virus or herpes simplex virus, rarely cytomegalovirus (CMV). ARN often occurs in healthy adults; occasionally affecting immunocompromised patients with poor prognosis including significant visual loss and detachment of the atrophic retina regardless of antiviral treatment. Read More

View Article and Full-Text PDF

Acute Retinal Necrosis: Signs, Treatment, Complications and Outcome.

Diagnostics (Basel) 2022 Feb 2;12(2). Epub 2022 Feb 2.

University Eye Clinic Heidelberg, Heidelberg University, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.

Background: The Acute Retinal Necrosis (ARN) is an inflammatory, rapidly progressive necrotizing retinitis and vasculitis, most frequently caused by Varicella-Zoster-Virus (VZV), followed by Herpes-Simplex-Virus (HSV), Cytomegalovirus (CMV) and Epstein-Barr-Virus (EBV). The diagnosis is based on clinical signs that were first defined by the American Uveitis Society in 1994 that include one or more foci of retinal necrosis, rapid progression without treatment, circumferential progression, occlusive vasculopathy, and inflammatory signs of the vitreous and anterior chamber Methods: In this retrospective analysis, we included 16 eyes of 10 patients, six patients with simultaneous or delayed bilateral affection, treated for ARN. Status of disease, corrected distance visual acuity (CDVA, decimal), intraocular pressure (IOP), pathogen proof, therapy, and complications were evaluated at diagnosis and 3 months later. Read More

View Article and Full-Text PDF
February 2022

Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

Curr Oncol 2022 01 24;29(2):490-496. Epub 2022 Jan 24.

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

Cytomegalovirus (CMV) retinitis is a rare end-organ disease of CMV infection and is a marker of severe immunosuppression, especially in human immunodeficiency virus (HIV)-positive patients. In multiple myeloma (MM) patients, CMV retinitis has been reported in the post-transplant setting, with an incidence lower than 0.2%, and in patients receiving lenalidomide. Read More

View Article and Full-Text PDF
January 2022

Occurrence of vernal keratoconjunctivitis in children infected with human immunodeficiency virus.

Indian J Ophthalmol 2022 Feb;70(2):497-499

Department of Ophthalmology, Shri Bhausaheb Hire Government Medical College, Dhule, Maharashtra, India.

Purpose: To study the occurrence of vernal keratoconjunctivitis (VKC) as an ocular manifestation of human immunodeficiency virus (HIV) in pediatric patients.

Methods: A retrospective study was done on the observations of cases of HIV-positive children. All seropositive patients from the Anti-Retroviral Therapy clinic were referred to the department of ophthalmology for evaluation. Read More

View Article and Full-Text PDF
February 2022

Effects of intraocular treatments for Epstein-Barr virus (EBV) retinitis: A case report.

Medicine (Baltimore) 2021 Dec;100(48):e28101

Department of Ophthalmology, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, Japan.

Rationale: Intraocular infection of Epstein-Barr virus (EBV) may cause severe visual loss. However, it is relatively rare, and there is no consensus on its treatment.

Patient Concerns: A 44-year-old woman complained of a right-eye floater and exhibited a unilateral exudative change along the retinal veins at the Department of Ophthalmology, St. Read More

View Article and Full-Text PDF
December 2021

Ganciclovir attenuates the onset and progression of experimental autoimmune uveitis by inhibiting infiltration of Th17 and inflammatory cells into the retina.

Biochem Pharmacol 2022 03 15;197:114917. Epub 2022 Jan 15.

Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, China. Electronic address:

Noninfectious (autoimmune and immune-mediated) uveitis is one of the primary diseases leading to blindness in the world. Due to the limitation of current first-line drugs for clinical uveitis, novel drugs and targets against uveitis are urgently needed. Ganciclovir (GCV), an FDA-approved antiviral drug, is often used to treat cytomegalovirus-induced retinitis in clinical patients. Read More

View Article and Full-Text PDF